Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep 6:11:1758835919869120.
doi: 10.1177/1758835919869120. eCollection 2019.

Current status of hepatocellular carcinoma detection: screening strategies and novel biomarkers

Walid S Ayoub  1 , Justin Steggerda  2 , Ju Dong Yang  1 , Alexander Kuo  1 , Vinay Sundaram  1 , Shelly C Lu  3
Affiliations
Review

Current status of hepatocellular carcinoma detection: screening strategies and novel biomarkers

Walid S Ayoub et al. Ther Adv Med Oncol. .

Abstract

Hepatocellular carcinoma (HCC) remains a major cause of cancer-related mortality worldwide. Delayed diagnosis is a major factor responsible for the poor prognosis of HCC. Several advances have been made in the field of liver imaging with the use of novel imaging contrasts, improving current imaging techniques with contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI), introduction of new technologies such as contrast liver ultrasound, and development of novel biomarkers with the goal of early detection of HCC and improving outcomes of patients with HCC. This review focuses on current surveillance strategies and development of biomarkers with the goal of early detection of HCC.

Keywords: CT; HCC; MRI; biomarkers; liquid biopsy; surveillance; ultrasound.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare that there is no conflict of interest.

References

    1. Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 2018; 67: 358–380. - PubMed
    1. Chiang CJ, Yang YW, You SL, et al. Thirty-year outcomes of the national hepatitis B immunization program in Taiwan. JAMA 2013; 310: 974–976. - PubMed
    1. Petrick JL, Braunlin M, Laversanne M, et al. International trends in liver cancer incidence, overall and by histologic subtype, 1978–2007. Int J Cancer 2016; 139: 1534–1545. - PMC - PubMed
    1. Zheng Z, Liang W, Milgrom DP, et al. Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies. Transplantation 2014; 97: 227–234. - PubMed
    1. Shah SA, Smith JK, Li Y, et al. Underutilization of therapy for hepatocellular carcinoma in the Medicare population. Cancer 2011; 117: 1019–1026. - PubMed